Title:
タキサン誘導体を含有する抗腫瘍組成物
Document Type and Number:
Japanese Patent JP4467885
Kind Code:
B2
Abstract:
A pharmaceutical composition comprised of acetocyclopropyl taxotere or a derivatve thereof, and at least one of an alkylating agent, an antimetabolite, a spindle poison, an epidophyllotoxin, an antibiotic, an enzyme, a topoisomerase inhibitor, a platinum coordination complex, a biological response modifier or a growth factor inhibitor is described.
Inventors:
Marie-Christine, Bisserie
Application Number:
JP2002572997A
Publication Date:
May 26, 2010
Filing Date:
March 21, 2002
Export Citation:
Assignee:
Aventis Pharma S.A.
International Classes:
A61K31/337; A61K45/00; A61K31/4375; A61K31/4745; A61K31/555; A61K31/565; A61K31/704; A61K31/7064; A61K33/243; A61K38/43; A61P35/00; A61P43/00
Domestic Patent References:
| JP8503205A |
Other References:
GELMON KA,JOURNAL OF CLINICAL ONCOLOGY,2000年12月15日,V18N24,P4098-4108
KURATA T,JOURNAL OF CLINICAL ONCOLOGY,2000年 9月,V18N17,P3164-3171
LOPES N M,CANCER CHEMOTHERAPY AND PHARMACOLOGY,ドイツ,SPRINGER VERLAG,1997年,V41N1,P37-47
KURATA T,JOURNAL OF CLINICAL ONCOLOGY,2000年 9月,V18N17,P3164-3171
LOPES N M,CANCER CHEMOTHERAPY AND PHARMACOLOGY,ドイツ,SPRINGER VERLAG,1997年,V41N1,P37-47
Attorney, Agent or Firm:
Patent business corporation Odashima patent office